Xultophy

Insulin degludec/liraglutide, sold under the brand name Xultophy, is a fixed-dose combination medication for the treatment of adults with type 2 diabetes to improve glycemic control in combination with diet and exercise.[4][5] It contains insulin degludec and liraglutide.[4][5] It is administered by subcutaneous injection.[4][5] The most common side effects include hypoglycaemia (low blood glucose)... [wikipedia]